The NPR Politics Podcast
SCOTUS Hears Abortion Pill Arguments
Mar 28, 2024
Selena Simmons-Duffin, NPR's health policy correspondent, dives into the Supreme Court's recent case on mifepristone, the abortion pill at the center of heated legal battles. The discussion includes skepticism from justices on the anti-abortion arguments against the FDA. Potential repercussions for healthcare providers as judges potentially influence medical decisions are also explored. Additionally, they dissect the business implications of legalizing mifepristone and how outdated laws like the Comstock Act impact abortion access today.
17:46
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- SCOTUS is skeptical of restricting access to mifepristone, with implications beyond abortion.
- Legal battles over Mifepristone could have lasting impacts on abortion laws and patient care.
Deep dives
Supreme Court Case on Mifepristone Accessibility
The Supreme Court heard arguments about the accessibility of Mifepristone used in medication abortions. The case started in 2022 after Roe v. Wade was overturned. The Alliance for Hippocratic Medicine, an anti-abortion group, sued the FDA, challenging the drug's approval process and increased accessibility since 2016. The case questions the rights of the group to sue the FDA and the FDA's decisions on Mifepristone accessibility.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
